Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1298
Selected: 0
NCT IDTitle
NCT01478490To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol
NCT01403818A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration
NCT00418873Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
NCT01232413A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects
NCT00892749Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
NCT04194697A Study to Assess Effect of Exercise Program Provided by Smartphone Application on the Body Composition
NCT00723073Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
NCT01284868A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
NCT00493324Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis
NCT02045459Microvascular Disease Exercise Trial
NCT03625505A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia
NCT01650194A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
NCT02751931Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
NCT01478503To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females
NCT02697877Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements
NCT02570841Pain Thresholds Under High-dose Topical Capsaicin
NCT07409272A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
NCT05495581A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well
NCT04655365Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
NCT01118572A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients
NCT01118559A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150
NCT05033886A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause
NCT02294461An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
NCT01630083Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer
NCT06072196A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
NCT04641260A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants
NCT01244763Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
NCT01913392Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate
NCT01215721Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)
NCT01088919A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects
NCT01650506Study of Erlotinib and Metformin in Triple Negative Breast Cancer
NCT00920998Effect of Food Intake on Pharmacokinetic Profiles of Z-338
NCT02964936A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
NCT02445612Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
NCT00036192Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
NCT02421939A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
NCT01911728Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
NCT01901107Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients
NCT03395197Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
NCT04501640A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants
NCT02171182A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain
NCT01870908Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients
NCT02965040A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function
NCT00568516Phase II Study of ASP3550 in Patients With Prostate Cancer
NCT01302158Drug-drug Interaction Study With ASP1941 and Glimepiride
NCT00721487Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
NCT07347314Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy
NCT03903094A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden
NCT04419402Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
NCT01186861Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy